Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Amendment to Loan Agreement

29 Mar 2021 16:30

Arricano Real Estate Plc (ARO) Amendment to Loan Agreement 29-March-2021 / 16:30 GMT/BST Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR), transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

 

29 March 2021

 

Arricano Real Estate Plc

(together with its subsidiaries "Arricano")

 

Amendment to the loan agreement

Arricano (AIM: ARO), a leading real estate developer and shopping mall operator in Ukraine, is pleased to announce the following update relating to its current loan facility with the TASCOMBANK JSC.

PRIVATE JOINT-STOCK COMPANY "UKRPANGROUP", a subsidiary of Arricano, on 26 March 2021, entered into an amendment to the current USD 12.0 million loan agreement with TASCOMBANK JSC to decrease the interest rate from 9.75% to 8% per annum. The loan is repayable in June 2024.

 

Enquiries:

Arricano Real Estate plc Tel: +357 25 582 535

Ganna Chubotina

 

Nominated Adviser and Broker: Tel: +44 (0)20 7220 1666

WH Ireland Limited

Chris Fielding

 

Financial PR: Tel: +44 (0)20 3151 7008

Novella Communications Limited

Tim Robertson/ Fergus Young


ISIN:CY0102941610
Category Code:MSCM
TIDM:ARO
LEI Code:213800F8AMPULEKXFX22
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State
Sequence No.:96533
EQS News ID:1179400
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS